Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin Inform patients that the risk of hypoglycemia is increased when RYBELSUS is used with an insulin secretagogue (such as a sulfonylurea) or insulin
First, it allows the gastrointestinal system to adapt to the medication's effects on gastric motility and emptying, thereby minimizing common adverse effects such as nausea, vomiting, diarrhea, and abdominal discomfort
Manage Stress Chronic stress is linked to high blood pressure, and it can also lead to unhealthy coping behaviors such as overeating or excessive alcohol consumption
This 60-year heritage speaks for itself
There were no significant differences between the duration of treatment or amelioration of withdrawal symptoms between tapering strategies of buprenorphine for opioid withdrawal
Assessment of risk of bias in included studies The quality of the studies included in this review was assessed by two independent reviewers using the Cochrane risk of bias tool 2 (RoB 2) [32]